Life science action: Diamics-Inverness, Codexis-Biocatalytics & Saratoga
In case you missed the action in life sciences last week, see David Hamilton’s posts on Diamics, a Novato company, selling 51 percent of itself to Inverness; the purchase by Redwood City Codexiis of BioCatalytics; and Saratoga Ventures raising of money.
Next Story: Blum Capital Partners raises between $2 and $2.5B
Previous Story: CoWare, provider of EDA software, raises $7M of planned $14M
About the Author, Matt Marshall
Matt launched VentureBeat in September of 2006, with the realization that no one else was covering the entrepreneurial and tech innovation scene with the velocity or depth that he was. Prior to founding VentureBeat, he covered venture capital for the San Jose Mercury News from 2001 to 2006. In 2002, Matt was awarded "Journalist of the Year" by the Northern California Society of Professional Journalists. Prior to working at the Merc, he was a correspondent for the Wall Street Journal in Bonn, Germany from 1995 to 1998, and a writer for the Washington Post in 1994. Matt holds a PhD in Government and an MA in German and European Studies from Georgetown University. In addition to VentureBeat, Matt is also the Executive Producer of DEMO, the leading launchpad event for emerging technologies.












